{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:23:03Z","timestamp":1788384183045,"version":"build-2803163510"},"publisher-location":"Berlin, Heidelberg","reference-count":14,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642787737","type":"print"},{"value":"9783642787713","type":"electronic"}],"license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-3-642-78771-3_30","type":"book-chapter","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T01:07:40Z","timestamp":1321837660000},"page":"391-401","source":"Crossref","is-referenced-by-count":24,"title":["Combination Therapy of Cutaneous T Cell Lymphoma with Interferon Alpha-2a and Photochemotherapy"],"prefix":"10.1007","author":[{"given":"R.","family":"Stadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Otte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"30_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/09546638909086685","volume":"1","author":"LR Braathen","year":"1989","unstructured":"Braathen LR, McFadden N (1989) Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alpha-2a. J Dermatol Treat 1:29\u201332","journal-title":"J Dermatol Treat"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-101-4-484","volume":"101","author":"PA Bunn Jr","year":"1984","unstructured":"Bunn PA Jr, Foon KA, Ihde DC et al (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101:484\u2013487","journal-title":"Ann Intern Med"},{"key":"30_CR3","first-page":"725","volume":"63","author":"PA Bunn","year":"1979","unstructured":"Bunn PA, Lamberg SI (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725\u2013728","journal-title":"Cancer Treat Rep"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"209S","DOI":"10.1111\/1523-1747.ep12875762","volume":"95","author":"PA Bunn","year":"1990","unstructured":"Bunn PA, Norris DA (1990) The role of interferons and monoclonal antibodys in cutaneous T-cell lymphomas. J Invest Dermatol 95:209S-212S","journal-title":"J Invest Dermatol"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2133.1989.tb15526.x","volume":"121","author":"B Dreno","year":"1989","unstructured":"Dreno B, Godefroy WY, Fleischmann M, Bureau B, Litoux P (1989) Low-dose recombinant interferon-alpha in the treatment of cutaneous T-cell lymphomas. Br J Dermatol 121:543\u2013544","journal-title":"Br J Dermatol"},{"key":"30_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/1097-0142(197608)38:2<683::AID-CNCR2820380210>3.0.CO;2-V","volume":"38","author":"BA Gilchrest","year":"1976","unstructured":"Gilchrest BA, Parish JA, Tannenbaum LR, Haynes Fitzpatrick TB (1976) Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 38:683\u2013698","journal-title":"Cancer"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0190-9622(92)70202-Q","volume":"27","author":"KB Holloway","year":"1992","unstructured":"Holloway KB, Flowers FP, Ramos-Caro FA (1992) Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:367\u2013378","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"30_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/jnci\/82.3.203","volume":"82","author":"TM Kuzel","year":"1990","unstructured":"Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA, Evans L, Roenigk HH, Rosen ST (1990) Interferon alpha-2a combined with photochemotherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82(3):203\u2013207","journal-title":"J Natl Cancer Inst"},{"key":"30_CR9","first-page":"695","volume":"43","author":"HG Otte","year":"1992","unstructured":"Otte HG, Herges A, Stadler R (1992) Kombinationstherapie mit Interferon alfa 2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43:695\u2013699","journal-title":"Hautarzt"},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"198S","DOI":"10.1111\/1523-1747.ep12875523","volume":"95","author":"HH Roenigh","year":"1990","unstructured":"Roenigh HH, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Vaiakojis D, Kaul K, Bunn PA, Evans L, Rosen ST (1990) Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95:198S\u2013205S","journal-title":"J Invest Dermatol"},{"key":"30_CR11","first-page":"93","volume":"1","author":"R Simoni","year":"1987","unstructured":"Simoni R, Cavalieri R, Coppola G, Ricciotti L, De Pita O, Criscuolo D, Covelli A, Papa G, Mandelli F (1987) Recombinant leukocyte interferon alpha-2a in the treatment of mycosis fungoides. J Biol Regul Homeost Agents 1:93\u201399","journal-title":"J Biol Regul Homeost Agents"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0190-9622(89)70078-5","volume":"20","author":"R Stadler","year":"1989","unstructured":"Stadler R, Mayer-Da-Silva A, Bratzke B, Garbe C, Orfanos C (1989) Interferons in dermatology. J Am Acad Dermatol 20:650\u2013656","journal-title":"J Am Acad Dermatol"},{"key":"30_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2133.1988.tb02600.x","volume":"118","author":"K Threstrup-Pedersen","year":"1988","unstructured":"Threstrup-Pedersen K, Hammer R, Kaltoft K, Sogaard H, Zachariae H (1988) Treatment of mycosis fungoides with recombinant interferon alpha-2a alone an in combination with etretinate. Br J Dermatol 118:811\u2013818","journal-title":"Br J Dermatol"},{"key":"30_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/archderm.123.6.757","volume":"123","author":"EC Vonderheid","year":"1987","unstructured":"Vonderheid EC, Thompson R, Smiles KA, Lattanand A (1987) Recombinant interferon alpha-2b in plaque-phase mycosis fungoides. Arch Dermatol 123: 757\u2013763","journal-title":"Arch Dermatol"}],"container-title":["Recent Results in Cancer Research","Skin Cancer: Basic Science, Clinical Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-78771-3_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T14:27:53Z","timestamp":1558189673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-78771-3_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9783642787737","9783642787713"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-78771-3_30","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}